The suppressor of forked (Su(f)) protein of Drosophila melanogaster is highly homologous to two proteins involved in mRNA 3′-end formation, the yeast RNA14 protein and the 77K subunit of human cleavage stimulation factor (CstF). This suggests a role for su(f) in mRNA 3′-end-processing, probably as part of Drosophila CstF. We have investigated the expression pattern of su(f) during Drosophila development and found that the su(f) gene product is not detected ubiquitously. The Su(f) protein accumulates in mitotically-active cells, but does not in non-dividing cells. This expression pattern corroborates earlier data suggesting that the phenotypes of su(f) mutants could result from a defect in cell proliferation. Our results suggest that, in Drosophila, Su(f) is involved in the regulatory function of CstF.
Introduction
mRNA processing has emerged as a widespread device for controlling gene expression during development. Differential RNA processing can occur at the level of both splicing and 3′-end formation, but, while some aspects of splicing regulation are beginning to be understood (reviewed in Chabot, 1996) , less is known about the regulation of mRNA 3′-end formation.
In Drosophila, mutations caused by insertion of transposable elements within non-coding sequences of genes have proven to be useful in identifying genes involved in mRNA processing (Zachar et al., 1987 (Zachar et al., , 1994 Rutledge et al., 1988; Fridell and Searles, 1994) . The suppressor of forked (su(f)) gene was identified due to its interaction with the forked 1 (f 1 ) mutant (Whittinghill, 1937) . The su (f) l allele is viable and suppresses the forked bristle phenotype of the f 1 mutation, where a gypsy retrotransposon is inserted in an intron of the forked (f) gene (Hoover et al., 1993; Ishimaru and Saigo, 1993) .
The su(f) gene encodes an 84-kDa protein which has been shown to share extensive homology with two proteins involved in mRNA 3′-end formation. The Su(f) protein is 26% identical and 47% similar to the yeast RNA14 protein (Mitchelson et al., 1993) . The RNA14 protein is part of cleavage factor I (CFI) which is required for both steps, pre-mRNA cleavage and polyadenylation, of the mRNA 3′ end-processing reaction in yeast . More strikingly, the Su(f) protein is 56% identical and 69% similar to the human 77K protein (Takagaki and Manley, 1994) , which is one of the three subunits of the human cleavage stimulation factor (CstF). CstF has a role in the first step of the mRNA 3′ end-processing reaction, the cleavage of pre-mRNA (Takagaki et al., 1989) . The high level of similarity extends over the entire length of the three proteins. This suggests a role for the Su(f) protein similar to that of the RNA14 and 77K proteins in mRNA 3′-end formation. In addition, such a role for su(f) is in good agreement with the phenotypes of viable su(f) alleles. In the f intron of f provokes a reduced amount of wild-type f transcripts and an accumulation of truncated transcripts polyadenylated in the 5′ long terminal repeat (LTR) of gypsy. The suppression of the f 1 phenotype in the double mutant f 1 su (f) 1 is correlated with an increase in the level of wildtype f transcripts which could result from a reduced utilisation of the poly(A) site in the 5′ LTR of gypsy (Ishimaru and Saigo, 1993) .
In higher eukaryotes, the mRNA 3′ end-processing reaction requires the assembly of a multicomponent complex, which includes CstF (reviewed in Keller, 1995; Manley, 1995; Wahle, 1995) . CstF consists of three subunits with molecular weights of 50 kDa, 64 kDa (64K) and 77 kDa (77K) (Takagaki et al., 1990) . While the interaction of CstF with the RNA substrate is mediated by the 64K subunit (Takagaki et al., 1990; MacDonald et al., 1994) , the 77K protein makes contact with the two other subunits of CstF (Takagaki and Manley, 1994) and with a protein from another complex, the cleavage and polyadenylation specificity factor (CPSF) (Murthy and Manley, 1995) . The strong identity between the 77K subunit of human CstF and the Su(f) protein suggests that Su(f) is part of a CstF complex in Drosophila. Moreover, the existence of a Drosophila CstF is reinforced by the finding that a Drosophila homologue of the 64K subunit of human CstF can interact in vitro with the human 77K subunit (Takagaki and Manley, 1994) .
Several data indicate that the CstF complex could be involved in regulation of poly(A) site selection. Whereas the CPSF complex of polyadenylation recognises and binds to the consensus polyadenylation signal, AAUAAA (Keller et al., 1991) , CstF binds to GU-rich sequences downstream of poly(A) sites (MacDonald et al., 1994) . These GU-rich sequences are highly variable between RNAs, and poly(A) site efficiency appears to depend on the stability of complex-formation involving CstF and the downstream GU-rich sequences (Weiss et al., 1991) . Moreover, changes in CstF activity have been shown to be correlated with a shift in the choice of poly(A) sites (Mann et al., 1993; Edwalds-Gilbert and Milcarek, 1995; Yan et al., 1995; Takagaki et al., 1996) .
The study of su(f) expression and requirement during development could provide a new approach to investigate the role of CstF in regulation of mRNA 3′-end formation. Previous developmental studies of su(f) have shown that null alleles of su(f) are lethal as first instar larvae (Perrimon et al., 1989; Lindsley and Zimm, 1992) . In addition, four temperature-sensitive alleles of su(f) which are viable at 25°C and lethal at 29°C have been used to show that su(f) is required at various stages of development, including larval, pupal (Dudick et al., 1974; Russel, 1974; Jürgens and Gateff, 1979) and ovarian development (Wilson, 1980; Lineruth and Lambertsson, 1986) . These data indicate that su(f) has a role in mRNA processing of one or more vital genes. However, up to now, no investigation was made to determine whether su(f) is involved in a particular developmental process.
To determine whether su(f) is involved in a regulatory mechanism allowing the control of a specific developmental process at the level of mRNA 3′-end formation, we have analysed its expression pattern. We found that the Su(f) protein is not detected ubiquitously. This protein specifically accumulates in dividing cells at various stages of development. These data corroborate earlier developmental studies of su(f). Moreover, they are in agreement with a role of CstF in regulation of the mRNA 3′ end-processing reaction and suggest a control of CstF activity at the level of the Su(f)/77K protein.
Results
We examined the expression pattern of su(f) by using a construct in which the lacZ gene of E. coli is cloned in frame downstream of the su(f) gene or by directly determining the location of the Su(f) protein with an anti-Su(f) polyclonal antibody. Fig. 1A . It contains the su(f) locus up to the beginning of the last exon fused to the lacZ gene, and it encodes a Su(f)-b-galactosidase fusion protein which is missing only 66 amino acids from the C-terminus of the Su(f) protein. This construct has the same 5′ sequence upstream of the transcription start site of su(f) as the construct BX64 that was shown to rescue null alleles of su(f) (Mitchelson et al., 1993) . Three independent lines containing P[su(f)-lacZ]G were obtained by transformation and mobilisation of one insertion with P transposase. All three lines show an identical expression pattern of the fusion protein.
The phenotypes of su(f) temperature-sensitive alleles indicate a requirement for su(f) function in oogenesis and in larval development. su(f) temperature-sensitive mutant females become sterile after three days at the restrictive temperature (Dudick et al., 1974; Wilson, 1980; Lineruth and Lambertsson, 1986) and su(f) temperature-sensitive mutant embryos die as second or third instar larvae when raised at the restrictive temperature (Dudick et al., 1974; Russel, 1974; Jürgens and Gateff, 1979) . We studied su(f) expression in adult ovaries and in larvae.
su(f) expression during oogenesis
X-Gal staining of ovaries shows that P[su(f)-lacZ]G is expressed both in follicle cells and in germ-line cells. The Su(f)-b-galactosidase protein is present in follicle cells in early stages of oogenesis only, up to stage 7, and is not detected in later stages (Fig. 1B) . During early stages (stages 2-6), follicle cells divide to keep up with the growth in eggchamber volume. After stage 6, follicle cells increase in size and migrate posteriorly to cover the oocyte (King, 1970 synthesised in earlier stages. Fig. 1B shows that P[su(f) lacZ]G is also expressed in the germ-line. Expression starts in the germarium, where stem cells are dividing and continues in the nurse cells at all stages of oogenesis. The Su(f)-b-galactosidase protein is poured into the oocyte, this suggests that the Su(f) gene product is provided maternally to the future embryo. The maternal effect of su(f) has been analysed (Perrimon et al., 1989) , however, strong alleles did not produce germ-line clones. Therefore, the survival of su(f) mutant embryos lacking a maternal contribution cannot be studied.
su(f) expression in third instar larvae
X-Gal staining of third instar larvae shows that P[su(f)-lacZ]G is strongly expressed in all imaginal tissues ( Fig.  1C-G ). Expression appears to be ubiquitous in all imaginal discs ( Fig. 1D-F ) except in the eye-antennal disc (Fig. 1C) . In most discs, imaginal cells divide actively throughout larval stages. Cessation of division occurs in a spatiallyand temporally-defined pattern specific to each disc, usually after pupariation (Cohen, 1993) . P[su(f)-lacZ]G is also expressed in histoblasts (Fig. 1G ). Unlike cells of imaginal discs, these cells do not divide during larval development, they are arrested in G2 interphase and start to divide rapidly 3 h after pupariation (Roseland and Schneiderman, 1979; Hayashi, 1996) . P[su(f)-lacZ]G expression is not detected in all tissues. X-Gal staining revealed that the fusion protein is not detected in fat body and in Malpighian tubules, which contain post-mitotic cells in third instar larvae (data not shown).
Dynamic expression of su(f) in eye-antennal imaginal disc and in larval brain
The eye-antennal imaginal disc shows a specific expression pattern of P[su(f)-lacZ]G (Fig. 1C) . In contrast to other imaginal discs, differentiation in the eye imaginal disc is initiated at late second instar. It starts at the posterior edge of the eye disc and progresses toward the anterior edge as a wave marked by a depression in the apical surface of the epithelium, called the morphogenetic furrow (MF) (Ready et al., 1976) . A third instar eye-antennal imaginal disc is schematised in Fig. 2A . Anteriorly to the MF, cells divide asynchronously. Immediately ahead of the MF, a mitotic domain allows a first step of cell-cycle synchronisation. In the MF, cells are synchronised in the G1 phase of the cell cycle. At the posterior edge of the MF, some cells form regular spaced preclusters that contain post-mitotic precursors for the first five photoreceptor cells. Before being included into the preclusters, the remaining cells undergo a synchronous round of divisions which is called the second wave of mitoses (Ready et al., 1976; Tomlinson, 1985; Tomlinson and Ready, 1987; Wolff and Ready, 1991; Thomas et al., 1994) 
. Expression of P[su(f)-lacZ]G is restricted to the anterior part of the third instar eye imaginal disc (Fig. 1C). To determine whether P[su(f)-lacZ]G is expressed
anteriorly to the MF, we studied its expression from late second instar to mid-third instar. Fig. 2B -D shows that expression of P[su(f)-lacZ]G seems to correlate with the progression of the MF. In the late second instar eye disc, where differentiation has not started, the fusion protein is ubiquitous. At later stages, when the MF has progressed anteriorly, expression of P[su(f)-lacZ]G is restricted to the anterior part of the disc. This suggests that accumulation of the fusion protein does not occur in post-mitotic differentiated cells.
Fig . 2F ,G shows that the expression pattern of P[su(f)-lacZ]G is also dynamic in the optic lobes of the brain during larval development. The larval brain consists of a ventral ganglion and two paired brain hemispheres where the developing optic lobes flank the midbrain laterally (White and Kankel, 1978) . In late second instar, expression is limited to the posterior edge of each optic lobe (Fig. 2F) . In mid-third instar, the Su(f)-b-galactosidase protein is distributed more anteriorly as a crescent in each optic lobe (Fig. 2G ). This crescent could correspond to the outer proliferative centre of the optic lobe. The outer proliferative centre contains cells that divide synchronously in two separate waves of mitoses before their differentiation into lamina neurones (Fig. 2E) . These waves progress from the posterior to the anterior edge of the optic lobes during larval development; in third instar, the posterior edge of each optic lobe contains post-mitotic differentiated lamina neurones (Selleck and Steller, 1991; Selleck et al., 1992) . Fig. 2G shows that the Su(f)-b-galactosidase fusion protein is not detected in this posterior region of the optic lobes.
The Su(f) protein accumulates in mitotically-active cells
An antibody against the Su(f) protein was raised in rabbit and affinity-purified. The specificity of the purified antibody, Rb 268p, was tested in vivo, using the UAS/Gal4 system (Brand and Perrimon, 1993) . A transgene UASsu(f) was constructed by inserting the su(f) cDNA into the pUAST vector (Brand and Perrimon, 1993) . After germ-line transformation, four independent lines containing UASsu(f) were obtained, two of which were selected for the experiment. Overexpression of su(f) was analysed in the wing imaginal disc, where expression of UAS-su(f) was driven by the ptc-Gal4 activator (patched-Gal4, Gal4 559.1 ) (Speicher et al., 1994) . As a control, wing imaginal discs of larvae expressing UAS-lacZ (Brand and Perrimon, 1993) under the control of ptc-Gal4 were stained with anti-bgalactosidase antibody. Fig. 3A shows that the activator ptc-Gal4 drives lacZ expression in a narrow stripe along the anterior-posterior compartment boundary in the entire wing disc, that mimics ptc expression (Johnson et al., 1995) . Wing discs of larvae expressing UAS-su(f) directed by ptcGal4 were stained with the Rb 268p antibody. Fig. 3B shows that strong staining appears in the expression domain of ptc, which reveals overproduction of the Su(f) protein. The staining is fainter and ubiquitous in the rest of the disc, and reveals the endogenous Su(f) protein. This result shows that the antibody Rb 268p recognises the Su(f) protein.
The Su(f) protein was detected in eye-antennal imaginal discs of third instar larvae using this antibody. Fig. 4A shows that the Su(f) protein is detected in the anterior part of the eye disc but not in the posterior region. To determine the posterior edge of Su(f) accumulation, we carried out double-staining with anti-cyclin B (Lehner and O'Farrell, 1990 ) and anti-Su(f) antibodies (Fig. 4B-D) . The cyclin B protein is required during the cell cycle for entry into mitosis. It accumulates in late G2 phase and early M phase and is rapidly degraded at the metaphase-anaphase transition (Murray et al., 1989; Whitfield et al., 1990; Ghiara et al., 1991) . In the eye-antennal imaginal disc, cyclin B is present in cells anterior to the MF that divide asynchronously and in cells undergoing the second wave of mitoses . Immunostaining of an eye-antennal imaginal disc with anti-cyclin B antibody is shown in Fig. 4C . Superimposition of both staining patterns (Fig. 4D ) reveals that the Su(f) protein is present in the anterior part of the disc up to the second wave of mitoses, but that it is not detected in differentiated cells posterior to the second wave of mitoses. (Selleck et al., 1992) . X-Gal staining of (F) late second instar larval brain and (G) mid-third instar larval brain. The lack of Su(f)-b-galactosidase protein in differentiated cells of the optic lobes is indicated by arrows. cells in G1 phase, in the MF, although accumulation in these cells seems to be lower (Fig. 4B) . A lower accumulation of the Su(f)-b-galactosidase fusion protein in cells in the MF can also be seen with X-Gal staining (Fig. 2D) .
We have shown that the Su(f) protein accumulates in dividing cells in larval brain also, using double-staining with anti-cyclin B and anti-Su(f) antibodies (Fig. 4E-G) . Anti-cyclin B antibody reveals cells which are in G2 and in M phases in both waves of mitoses of the outer proliferative centre (Fig. 2E) (Selleck et al., 1992; Nakato et al., 1995) . Thus, for each optic lobe, anti-cyclin B staining appears as two concentric crescents (Fig. 4F) . Fig. 4E shows that antiSu(f) staining also appears as two concentric crescents in the optic lobe. The superimposition of both staining patterns (Fig. 4G) indicates that the Su(f) and the cyclin B proteins are detected in the same domains. These results show that the Su(f) protein accumulates in mitotically-active cells in the optic lobes of the brain. Double-staining of third instar larval brains with anti-cyclin B and anti-Su(f) antibodies also reveals the presence of the Su(f) protein in the neuroblasts of the ventral ganglion (Fig. 4H) . During larval development, neuroblasts of the ventral ganglion divide asynchronously (White and Kankel, 1978; Truman and Bate, 1988) . Fig. 4H shows that the Su(f) protein is present in cyclin B-containing neuroblasts.
These data show that the Su(f) protein is not ubiquitously distributed. It accumulates in mitotically-active cells in larvae. 
Cellular localisation of the Su(f) protein
The Su(f) protein is believed to have a role in mRNA 3′-end-processing, thus, it should be located, at least in part, in the nucleus. Indeed, a bipartite nuclear localisation signal has been identified in the central region of the Su(f) protein (Takagaki and Manley, 1994) . Immunostaining of third instar brains with anti-Su(f) antibody reveals that, in neuroblasts, the Su(f) protein is both nuclear and cytoplasmic (Fig. 4H) . We used the P[su(f)-lacZ]G construct to try to determine in which compartment the su(f) function is required. The fusion protein contains the complete Su(f) protein except 66 amino acids from its C-terminus, and it has the putative nuclear localisation signal of Su(f). However, X-Gal staining of histoblasts (Figs. 1G and 5A) shows that the fusion protein Su(f)-b-galactosidase is located in the cytoplasm. We have analysed the genetic properties of the P[su(f)-lacZ]G construct and found that it does not rescue the lethal phenotype of the deletion allele su(f) L26 . In contrast, this construct is able to rescue the lethality of the hypomorphic allele, su(f) R-9-18 . su(f) R-9-18 complements several other su(f) lethal alleles and this interallelic complementation suggests protein-protein interaction between Su(f) molecules (Simonelig et al., 1996) . Fig. 5B shows that in the viable combination su(f) R-9-18 ; P[su(f)-lacZ]G, the Su(f)-b-galactosidase fusion protein is present primarily in the nucleus. This could be explained by an interaction between the fusion protein and the protein encoded by su(f) R-9-18 . This heterodimerisation would result in a partly functional Su(f) complex translocated within the nucleus. This result suggests that su(f) function is required within the nucleus. The lack of nuclear localisation of the fusion protein in a su(f) wild-type background could result from the fact that interaction between wild-type Su(f) molecules is optimum and that this prevents interaction between the fusion protein and the wild-type Su(f) protein.
Discussion

The Su(f) protein specifically accumulates in mitotically-active cells
Using a su(f)-lacZ construct and an antibody against the Su(f) protein, we have shown that the Su(f) protein accumulates in dividing cells, in adult ovaries and in larvae. In ovaries, the Su(f)-b-galactosidase protein is detected in follicle cells, when these cells are dividing only. In third instar larvae, the Su(f)-b-galactosidase protein is present at a high level in dividing cells of imaginal discs. X-Gal and antibody staining shows that the Su(f) protein is not ubiquitously distributed in the eye imaginal disc. Its accumulation appears to be restricted to the part of the disc where cells are undergoing the cell cycle. Indeed, double-antibody staining with anti-Su(f) and anti-cyclin B antibodies indicates that the Su(f) protein is present in the anterior part of the eye disc up to the second wave of mitoses. Therefore, this protein is found in asynchronously-dividing cells anterior to the MF, in G1 cells in the MF and in G2-M cells in the second wave of mitoses. In larval brain, the Su(f) and the cyclin B proteins are present in the same domains, which correspond to G2-M cells present in both waves of mitoses of the outer proliferative centre. Presence of the Su(f) protein in G1 cells in this tissue could not be confirmed, due to the difficulty of visualising G1 cells, without cyclin B, between both waves of mitoses (Nakato et al., 1995) . Detection of the Su(f)-b-galactosidase protein in third instar histoblasts, is in agreement with the presence of the Su(f) protein in the G2 phase of the cell cycle since histoblasts, which do not divide at this stage of development, are known to be blocked in the G2 phase (Hayashi, 1996) . Our results show that the Su(f) protein accumulates in cells undergoing the cell cycle at various stages of development, but does not accumulate at a high level in post-mitotic differentiated cells such as ommatidia in the eye imaginal disc, or lamina neurones in larval brain.
The expression pattern of su(f) suggests that su(f) could be required during the cell cycle and a role of su(f) in cell proliferation has already been proposed (Wilson, 1980) . Earlier developmental studies of su(f), using the temperature-sensitive lethal alleles su (f) ts726 (Russel, 1974) and su (f) madts (Jürgens and Gateff, 1979) have shown that su(f) mutant mitotic clones cannot be obtained. Null alleles of su(f) do not produce germ-line clones either (Perrimon et al., 1989) . In addition, for three su(f) temperature-sensitive alleles, su(f) ts67g , su (f) madts and su(f) ts726 , homozygous mutant larvae die as third instar when they are shifted to the restrictive temperature before the end of second instar (Dudick et al., 1974; Russel, 1974; Jürgens and Gateff, 1979) . It was 
reported that su(f) ts726 early embryos shifted to the restrictive temperature die as third instar larvae with imaginal discs that are extremely reduced in size (Russel, 1974) These data are consistent with the expression pattern of su(f) and are in agreement with a role of su(f) in cell proliferation. Moreover, we have investigated the phenotype of the su(f) mutants and we have found that su(f) is required for progression through metaphase (A. Audibert and M. Simonelig, unpublished data).
Role of su(f) in regulation of mRNA 3′-end formation
Several lines of evidences suggest that the Su(f) protein is involved in mRNA 3′-end formation, probably as part of a Drosophila CstF complex (see Section 1). Immunostaining reveals that the Su(f) protein is detected both in the cytoplasm and in the nucleus. Nevertheless, genetic data indicate that su(f) function is required within the nucleus. This is in agreement with a role for the Su(f) protein in the mRNA 3′ end-processing reaction. We do not know the role of the Su(f) protein in the cytoplasmic compartment, however the yeast homologue of Su(f), the RNA14 protein, has also been shown to be present both in the cytoplasm and in the nucleus (Bonneaud et al., 1994) . As the 77K protein of human CstF is the only protein, among the three proteins of this complex, which contains a nuclear localisation signal, it has been proposed that assembly of CstF in the cytoplasm could be a prerequisite for its transport into the nucleus (Takagaki and Manley, 1994) . Therefore the amount of the 77K protein, or the Su(f) protein in Drosophila could regulate the amount of functional CstF in the nucleus.
As mentioned above, CstF could be involved in regulation of poly(A) site selection. CstF binds to highly variable GU-rich sequences located downstream of poly(A) sites (MacDonald et al., 1994) . This interaction appears to define the stability of the polyadenylation complex around poly (A) sites and would determine poly(A) site strength (Weiss et al., 1991) . In agreement with a regulatory role of CstF, changes in the 64K subunit of CstF have been shown to be responsible for changes in poly(A) site selection in the immunoglobulin M heavy-chain pre-mRNA. In the immunoglobulin M heavy-chain transcription unit, two poly(A) sites co-exist, a downstream strong poly(A) site and an upstream weak poly(A) site, located in an intron. Use of the downstream poly(A) site occurs primarily in the pre-B and B cells and leads to the synthesis of a membrane-bound form of the immunoglobulin, whereas, use of the upstream poly(A) site is preferential in differentiated plasma cells and leads to the formation of a secreted form of the immunoglobulin (reviewed in Peterson, 1994) . The shift from the membrane form poly(A) site to the secreted form poly(A) site during B-cell differentiation appears to result from either an increase in the binding activity of the 64K protein in plasma cells (Edwalds-Gilbert and Milcarek, 1995) , or an increase in the accumulation of the 64K protein in B cells induced to differentiate (Takagaki et al., 1996) . This change at the level of the 64K protein would allow the use of the weak secreted form poly(A) site in plasma cells.
Our developmental study of su(f) indicates that the Su(f) protein does not accumulate ubiquitously. The Su(f) protein is present at a high level in mitotically-active cells, but is not in non-dividing cells. These observations as well as the role of su(f) in cell division suggest that the Su(f) protein could be involved in a regulatory mechanism at the level of mRNA 3′-end formation, that would be required during cell-cycle progression. Recently, a correlation was also established between cell proliferation and high levels of cleavage-polyadenylation factors, including the 64K and the 50K subunits of CstF, in human culture cells induced to proliferate (C. Milcarek, pers. commun.) . Two alternative hypotheses could account for the differential accumulation pattern of the Su(f) protein. According to the first hypothesis, the Su(f) protein would be included in a sub-fraction of CstF complexes only. These Su(f)-containing CstF would be formed in mitotically-active cells and would have a role in 3′-end formation of specific mRNAs expressed during cell-cycle progression. In this model, the composition of CstF could vary in different tissues and Su(f) would not be the only protein able to provide the function of the 77K protein in Drosophila CstF.
By the second hypothesis, the Su(f) protein would be a constant constituent of CstF and a difference in Su(f) concentration between tissues would ensure the regulation. By this model, the amount of Su(f) protein would be a limiting factor in the formation of functional CstF. In tissues where the Su(f) protein is not detected, a very low amount of this protein would be present, allowing the formation of a low amount of CstF. This low amount of CstF would be sufficient for 3′-end formation of most mRNAs, however, polyadenylation of specific mRNAs expressed during cell-cycle progression would require a higher amount of CstF. 3′-end formation of these particular mRNAs would be preferentially affected by a decrease of su(f) activity, in su(f) mutants. This type of developmental regulation which relies on upregulation of a general factor has already been proposed. For example, Xenopus mesoderm induction in early embryos is brought about by elevated levels of the general translation factor eIF4E. A high amount of eIF4E appears to specifically stimulate translation of the mesoderm-inducer activin mRNA, without affecting total protein synthesis (Klein and Melton, 1994) .
Our results corroborate the conclusion that changes in CstF could lead to regulation of poly(A) site use and indicate that another subunit of CstF, the Su(f)/77K protein could be responsible for this regulation.
Experimental procedures
Fly strains and germ-line transformation
The su(f) alleles used in this study are described by Simonelig et al. (1996) . Gal4 and UAS lines used were ptcGa14 559.1 (Speicher et al., 1994) and UAS-lacZ (Brand and Perrimon, 1993) . The P[su(f)-lacZ]G transgene was made as follows. A BamHI-EcoRI fragment containing the lacZ gene of E. coli and the SV40 small t polyadenylation signal was cut out from the pC4b-gal plasmid (Thummel et al., 1988) , and inserted into the pWBX64 plasmid (Mitchelson et al., 1993) digested with BamHI and NotI, after filling-in of the EcoRI and NotI sites using Klenow. pWBX64 contains a 6.4-kb XbaI-BamHI fragment spanning the su(f) locus, in the pW8 vector (Klemenz et al., 1987) . The resulting construct was then digested with BamHI and BglII and religated after filling-in of both sites using Klenow. In this last construct, lacZ is fused in frame to the last exon of su(f) at the BglII site. The UAS-su(f) transgene was made by cloning a 2.5-kb EcoRI-EcoRI fragment of pcK22, containing the complete su(f) cDNA (Mitchelson et al., 1993) , into the pUAST vector (Brand and Perrimon, 1993 ) digested with EcoRI. P-element-mediated transformation was as described by Rubin and Spradling (1982) . The constructs were injected into w 1118 embryos using the plasmid pUChsPD2-3 as helper. One transformant bearing the P[su(f)-lacZ]G insertion on the X chromosome was obtained. Secondary insertion lines were generated by mobilisation of the primary insertion with D2-3(99B) (Robertson et al., 1988) . Two lines with unique secondary insertions on chromosome II and on chromosome III, respectively, were used in further analyses. The number and integrity of the transgenes were analysed by DNA blotting. Four independent lines bearing the UAS-su(f) transgene were obtained and two, one with the insertion on chromosome II and one with the insertion on chromosome III, were selected for the experiment.
Anti-Su(f) antibody
A 2.1-kb SalI-PstI fragment encoding 702 amino acids of the 733 residues of the su(f) open reading frame, was cloned into the E. coli expression vector pUR288 (Rüther and Müller-Hill, 1983) . Upon induction, this construct expressed a soluble fusion protein which was isolated by preparative gel electrophoresis. Rabbits were immunised by subcutaneous injection of 200 mg of fusion protein in 500 ml of an emulsion of PBS and complete Freund's adjuvant (1:1). Booster injections containing 100 mg of fusion protein in incomplete Freund's adjuvant were administered at monthly intervals. Blood was removed 7 days after each booster injection. Serum obtained after the last booster injection (Rb 268) was affinity-purified as follows. Expression of fusion protein was induced in growing bacterial culture by adding isopropyl-b-D-thiogalactoside (IPTG) to 1 mM and incubating for 3 h at 37°C. Proteins were resolved by preparative gel electrophoresis (SDS-PAGE). After electrotransfer to nitrocellulose paper, the proteins were visualised by ponceau S staining. The band corresponding to the fusion protein was cut out, blocked with TTBS (25 mM Tris-HCl, pH 7.5; 140 mM NaCl; 2.6 mM KC1; 0.2% Tween 20) supplied with 5% of milk and incubated for 3 h with 1:10 dilution of the serum Rb 268. After washing with four changes of TTBS over 30 min. the Su(f)-specific antibody was released from the paper with 100 mM glycine, pH 2.5, and immediately neutralised by adding two volumes of 1 M Tris-HCl, pH 8. The purified antibody Rb 268p was dialysed against PBS.
Histochemistry
Dissected larvae and adult ovaries were fixed in 0.5% glutaraldehyde in PBS pH 7.5, for 15 and 4 min, respectively. The tissues were washed in PBS, submerged in 0.1% 5-bromo-4-chloro-3-indolyl b-D-galactopyranoside (X-Gal), 3.5 mM K 4 Fe(Cn) 6 , 3.5 mM K 3 Fe(Cn) 6 , 1 mM MgCl 2 in PBS and incubated at 37°C. These preparations were mounted in 50% glycerol, 50% ethanol.
Antibody staining
Staining of imaginal discs was performed as described by Struhl and Basler (1993) , except that permeabilisation was in PBS, 0.3% Tween, for 10 min. and the subsequent steps were in PBT (PBS, 0.1% Tween). For larval-brain staining, larvae were dissected in PBS pH 7.5 and fixed in PBS, 50 mM EGTA, 3.7% formaldehyde, for 20 min. They were washed in PBS, permeabilised in PBS, 1% Triton for 30 min. and blocked in PBTBS (PBS, 0.1% Tween, 0.1% BSA, 2% serum) for 30 min. Incubation in PBTBS with the primary antibody was performed overnight at 4°C. The tissues were washed in PBT, blocked in PBTBS for 1 h and incubated with appropriate secondary antibody for 2 h at room temperature. The tissues were washed with four changes of PBT over 1 h. Antibodies used were: anti-bgalactosidase (Boerhinger), 1:200; anti-cyclin B raised in mouse (Lehner and O'Farrell, 1990) , 1:2; anti-Su(f) Rb 268, 1:500; anti-Su(f) Rb 268p, 1:200; biotinylated antirabbit or anti-mouse IgG (Vectastain), 1:500; rhodamine conjugated anti-rabbit or anti-mouse IgG (Biosys), 1:50; FITC conjugated anti-rabbit or anti-mouse IgG (Institut Pasteur Production), 1:200. The chemical reaction was performed with the ABC Elite kit (Vectastain). Mounting was done in 50% glycerol, 50% ethanol or in Citifluor for immunofluorescence. Confocal microscopy was carried out using a MRC 600 Bio-Rad confocal microscope.
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